|
SCP2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.2882999999595E-06 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.387600E-04 |
| Normal-vs-Stage2 |
7.297600E-02 |
| Normal-vs-Stage3 |
2.30179999999303E-05 |
| Normal-vs-Stage4 |
2.43079999462381E-08 |
| Stage1-vs-Stage2 |
2.885600E-01 |
| Stage1-vs-Stage3 |
1.955350E-01 |
| Stage1-vs-Stage4 |
7.216700E-03 |
| Stage2-vs-Stage3 |
8.522300E-02 |
| Stage2-vs-Stage4 |
6.380700E-03 |
| Stage3-vs-Stage4 |
1.245250E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.32370000005544E-06 |
| Normal-vs-AfricanAmerican |
2.335000E-01 |
| Normal-vs-Asian |
2.188700E-04 |
| Caucasian-vs-AfricanAmerican |
2.408600E-01 |
| Caucasian-vs-Asian |
9.116800E-01 |
| AfricanAmerican-vs-Asian |
2.196800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.177730E-04 |
| Normal-vs-Female |
1.70315999999948E-05 |
| Male-vs-Female |
6.976800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.001890E-04 |
| Normal-vs-Age(41-60Yrs) |
1.5188999999971E-05 |
| Normal-vs-Age(61-80Yrs) |
3.390200E-04 |
| Normal-vs-Age(81-100Yrs) |
9.488400E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.891600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.454600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.876400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.123000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.735800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.852400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
5.601600E-01 |
| Classical-VS-Follicular |
4.182000E-04 |
| Classical-VS-Other |
7.945600E-01 |
| Classical-VS-Normal |
2.78129999997656E-06 |
| Tall-VS-Follicular |
2.279400E-03 |
| Tall-VS-Other |
5.651400E-01 |
| Tall-VS-Normal |
2.787200E-04 |
| Follicular-VS-Other |
3.467400E-01 |
| Follicular-VS-Normal |
5.309600E-01 |
| Other-VS-Normal |
1.043790E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.77530000000337E-05 |
| Normal-vs-N1 |
9.09299999740654E-08 |
| N0-vs-N1 |
1.980280E-02 |
|
|
